Bifidobacteria
Cross-source consensus on Bifidobacteria from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Benefits
Risks & contraindications
Evidence quality
Other
Highlighted claims
- Bifidobacteria are the dominant beneficial bacteria in the infant gut and a critical driver of healthy microbiome development. — Maternal and Infant Gut Health: The First 10,000 Days
- The clinically validated Bifidobacteria species for infant gut health are B. infantis, B. longum, B. bifidum, and B. breve. — Maternal and Infant Gut Health: The First 10,000 Days
- B. dentium and B. adolescentis should not dominate the infant gut. — Maternal and Infant Gut Health: The First 10,000 Days
- Bifidobacteria continue to support children and adults by producing lactate and acetate and cross-feeding other beneficial short-chain fatty acid producers. — Maternal and Infant Gut Health: The First 10,000 Days
- About 90% of U.S. infants no longer have B. infantis due to widespread antibiotic use across generations. — Maternal and Infant Gut Health: The First 10,000 Days
- Targeted supplementation may be necessary when a mother lacks B. infantis and cannot pass it on. — Maternal and Infant Gut Health: The First 10,000 Days